US|EN
Select your region & language
Our content and services may vary by location.
US|EN
Back
Smiling employee in a conversation with a colleague in the office
Smiling employee in a conversation with a colleague in the office
ID: 113694

Interim Head of Sales

  • Pharma & Biotech
  • Asap
  • Interim Business Unit Head, Sales, SFE, Marketing
  • K-Recruiting GmbH
Contact:

Julius Strack

+49 89 1890998-614

julius.strack@k-recruiting.com

Overview

Availability
Asap, full-time, onsite & remote
Qualification
Pharmaceutical studies, Certified pharmaceutical officer (§75 AMG)
Language Skills
German (native), English (business fluent)
Relevant Expertise
Business Unit Head, Interim Management, Sales / Sales Optimisation, SFE, Marketing / Strategy Development and Implementation, Change Management, Performance Improvement / Turnaround, Crisis Intervention

Key-Facts

  • Highly accomplished Consultant with a track record of improving business performance, e.g. with SFE or marketing excellence measures

  • Successfully optimised sales strategy, developed new business model, implemented analytics and reports for sales & marketing teams

  • Passion for „Positive High-Performance Leadership“

  • Pragmatic, fast, solution-oriented and hands-on in taking on interim projects

  • We have recruited him before and received excellent feedback

Extract from previous activities

Pharmaceutical Company, Germany

Interim Head of Sales

Core Competencies: Sales Management, Process Optimization, Project Management

  • Personnel Responsibility: 50-200, number of direct reports: 10

  • Context: Restructuring

Main areas of responsibility:

  • Sales Director & member of the management team

  • Restructuring of the sales force and the business analytics team incl. reconciliation of interests and social plan (40% reduction in headcount)

  • Introduction of KPI-orientated management processes and a new communication and management model

  • Evaluation and identification of the broad portfolio with regard to the right sales channel mix

  • Ensuring cultural change and performance management

  • Preparing the succession of the Sales Director

Significant results:

  • YoY growth of 26% (as of March 2024) and growth on budget

  • Share price at 6-month high

  • Restructuring completed after 6 months, including filling all vacant positions

  • Implementation of a new key performance indicator system incl. reporting

  • New territory structure, including segmentation and targeting, rolled out

  • Training programme for managers and sales force developed and launched

  • 2 "talents" recruited

  • Cultural change initiated and contributed measurably to growth

Pharmaceutical Company, Germany

Interim Business Unit Head Rx Germany & Austria

Core Competencies: Change Management, HR Strategy, Sales Management

  • Personnel Responsibility: 10-50, number of direct reports: 6

  • Context: Strategic Positioning

Significant responsibilities:

  • Head of RX business including 3 business franchises and a launch team

  • Member of the GER & AT Management Team

  • Define the “ready for future” strategy for GER & AT Rx business entering biologics markets

Significant results:

  • Delivering 18 % organic growth with inline products

  • Successfully negotiated a co-promotion agreement with a leading pharma company

  • Implementing SFE / MEX structures from scratch, including segmentation and targeting processes

  • Delivering significant HR change and performance management

  • Implementing an integrated portfolio strategy to utilize synergies within the 3 business units

Pharmaceutical Company, Germany

Interim Senior Director Business Unit Specialty Products

Core Competencies: Innovation Management, Sales, Key Account Management

  • Personnel Responsibility: 10-50, number of direct reports: 3

  • Context: Operational management

Significant responsibilities:

  • Overall management of the speciality business in Germany and contributing to regional development

  • Performance management and delivering change

  • Member of the European Disease Area Strategy Team, D/A/CH Senior Leadership Team and the EU launch team

Significant results:

  • Achieved YTD net sales growth, +27 %

  • Implemented a strategy to address patient needs, improving patient time to therapy, including diagnosis optimization

  • Won 37 excellence nephrology centers and addressed referral structures through a multichannel campaign (geo-targeted approach)

  • Negotiated national “fast-path” appointments for patients in radiology centers

  • Close x-functional cooperation with PAGs, including regionalized PR campaigns and meetings

  • Build a new high-performance team from scratch with profitability on track within the restructuring process

  • Full restructuring and turnaround. Design and execution of transition strategies to new products